title: Guidelines for the use of epoetin: have quality-of-life benefits been proven?
authors.forename: Andrew
authors.initials: A
authors.lastname: Bottomley
authors.forename: Ronald
authors.initials: R
authors.lastname: Thomas
authors.forename: Kristel
authors.initials: K
authors.lastname: Van Steen
authors.forename: Henning
authors.initials: H
authors.lastname: Flechtner
authors.forename: Alexander
authors.initials: A
authors.lastname: de Graeff
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy*; D011788:Quality of Life; D011994:Recombinant Proteins
chemical_list: D011994:Recombinant Proteins; C103998:epoetin beta; D004921:Erythropoietin